Opthea failure hits Regal FUM
The failure of a clinical trial by biotech firm Opthea has caused shares in its backer Regal Partners to decline...
The failure of a clinical trial by biotech firm Opthea has caused shares in its backer Regal Partners to decline...
The case for cryptocurrency as “digital gold” is losing momentum as physical gold continues to demonstrate its ability to shine...
ETFs offering exposure to China, gaming, and the broader gold thematic were among the greatest performers in the year ending...
Clime has joined the growing list of investment managers reshaping their portfolios in response to mounting concerns over the unfolding...
GQG Partners has revealed its quarterly flows for the first three months of 2025, amid a continued repositioning in response...
The Reserve Bank of Australia (RBA) could deliver a 50 basis point cut as early as May, as spiralling global...
New data has shown a progressive deterioration in risk appetite among instos even prior to Trump’s latest round of tariffs.
With the slump in certain segments of the equities market reflected in investor flows, the local exchange-traded fund (ETF) industry...
The investment manager has witnessed further outflows amid projections that its FUM will continue to decline.
Lakehouse Capital has listed its first exchange-traded fund (ETF) on the ASX.
Global dividends surged to a record US$518.7 billion in Q3 2025, up 6.2% year-on-year, with financials leading the way. The...
Over the past 15 years, middle market direct lending has grown into one of the most dynamic areas of alternative...
For most Australians, superannuation is their largest financial asset outside the family home. So, when it comes to digital security,...
In financial markets, drama makes headlines. Share prices surge, tumble, and rebound — creating the stories that capture attention. But...
